The 4-(5-fluoro-6-methyl-pyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-ylamine 3 is a potent and selective inhibitor of TGF-betaR1. Substitution of the amino group of 3 typically led to a slight decrease in the affinity for the receptor and in TGF-beta-inducted PAI-luciferase reporter activity. However, 2-acetamidoimidazoles were identified as attractive candidates for further optimization as a result of their significant activity combined to their superior pharmacokinetic profile.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2008.11.119 | DOI Listing |
Publication Analysis
Top Keywords
2-aminoimidazoles inhibitors
4
inhibitors tgf-beta
4
tgf-beta receptor
4
receptor 4-5-fluoro-6-methyl-pyridin-2-yl-5-quinoxalin-6-yl-1h-imidazol-2-ylamine
4
4-5-fluoro-6-methyl-pyridin-2-yl-5-quinoxalin-6-yl-1h-imidazol-2-ylamine potent
4
potent selective
4
selective inhibitor
4
inhibitor tgf-betar1
4
tgf-betar1 substitution
4
substitution amino
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!